Patients with a nonrejection-related diagnosis according to the 2019 Banff classification who were reclassified as MVI, ...

Lipocine (LPCN) announced that the FDA has recently informed sponsors of approved testosterone products about class-wide labeling changes. This ...

Risk factors are things that change our likelihood of developing a disease. Factors that may increase our risk of developing vascular dementia include age, genetics, lifestyle, and other health ...

A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment ...

An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of ...

Accurate evaluation of retinal vascular networks at a micro-level could significantly improve our understanding of angiopathology and potentially aid ophthalmologists in disease assessment and ...

Notably, the findings from this work may provide novel insight into the underlying mechanisms of PAD and, perhaps, have prevention or therapeutic ...

The following is a summary of "Engineering approach to study the effect of TEVAR on the cardiovascular system: A systematic ...

A free congenital heart disease screening camp for children between the ages of 0-18 years was held at District Hospital ...